Pharmacokinetics of desogestrel

American Journal of Obstetrics and Gynecology

Volumn 168, Issue 3 PART 2, 1993, Pages 1021-1028

  McClamrock, Howard D ^a   Adashi, Eli Y ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

desogestrel; pharmacokinetics; Progestin; protein binding

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTAGEN; GESTODENE; LEVONORGESTREL; NORETHISTERONE; SEX HORMONE BINDING GLOBULIN;

FEMALE; HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

BIOLOGY; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; DESOGESTREL--PHARMACODYNAMICS; FAMILY PLANNING; LITERATURE REVIEW; METABOLIC EFFECTS; PHYSIOLOGY;

BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CARRIER PROTEINS; DESOGESTREL; FEMALE; HUMAN; INTESTINES; LIVER; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0027478825     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(93)90332-D     Document Type: Article

References (32)

1. Pharmacokinetics of estrogens and progestogens
2. Desogestrel and gestodene in oral contraception: a review of European experience
3. a new progestogen
4. review of pharmacology and clinical trials
5. Potency and pharmacokinetics of gestagens
6. Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel
7. Pharmacokinetics of progestogens
8. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin
9. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel
10. Comparative study of lipid metabolism and endocrine function in women receiving levonorgestrel- and desogestrel-containing oral contraceptives
11. Divergent effects of two lowdose oral contraceptives on sex hormone-binding globulin and free testosterone
12. Influence of purified plasma proteins on testosterone uptake and metabolism by normal and hyperplastic human prostate in "constant-flow organ culture."
13. Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel
14. Effect of two oral contraceptives containing 30 Ng ethinyl estradiol and 75 µg gestodene or 150 µg desogestrel upon various hormonal parameters
15. Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels
16. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinyl estradiol in human serum
17. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high-density lipoprotein
18. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinyl estradiol
19. Progestagen-dependent effect on some plasma proteins during oral contraception
20. Plasma hormone levels in women receiving new oral contraceptives containing eth-inyl estradiol plus levonorgestrel or desogestrel
21. Effects of seven low-dose combined oral contraceptives on sex hormone-binding globulin, corticosteroid-binding globulin, total and free testosterone
22. Effects of various combined oral contraceptives on sex steroids, gonadotropins and SHBG
23. A new low-dose estrogen oral contraceptive combination: effect of endocrine parameters and lipid status
24. Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives contain ing desogestrel or levonorgestrel
25. Serum levels of 3keto-desogestrel and SHBG during 12 cycles of treatment with 30 µlg ethinyl estradiol and 150 µg desogestrel
26. Short-term effects of desogestrel and ethinyl estradiol on serum proteins in women
27. The effect of age, weight-related parameters and hormonal contraceptives on andrological assays
28. Effects of three low-dose oral contraceptive combinations on sex hormone-binding globulin corticosteroid-binding globulin and antithrombin III activity in healthy women two monophasic desogestrel combinations (containing 0020 or 0030 mg ethinyl estradiol) and one triphasic levonorgestrel combination
29. Estroprogestogen combinations: effect on sex steroid-binding protein (SBP) synthesis
30. Single-dose pharmacokinetics of gestodene in women after intravenous and oral administration
31. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood